NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
<p>There are no clinically useful inhibitors of metallo-Β-lactamases (MBLs), which are a growing problem because they hydrolyse almost all Β-lactam antibacterials. Inhibition by most reported MBL inhibitors involves zinc ion chelation. A structure-based virtual screening approach combined with...
Main Authors: | Li, G, Abboud, M, Brem, J, Someya, H, Lohans, C, Yang, S, Spencer, J, Wareham, D, McDonough, M, Schofield, C |
---|---|
Format: | Journal article |
Published: |
Royal Society of Chemistry
2017
|
Similar Items
-
Use of ferrous iron by metallo-β-lactamases.
by: Cahill, S, et al.
Published: (2016) -
In silico fragment based design identifies subfamily B1 metallo-β-lactamase inhibitors
by: Cain, R, et al.
Published: (2017) -
Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition.
by: Brem, J, et al.
Published: (2014) -
Faropenem reacts with serine and metallo-β-lactamases to give multiple products
by: Lucic, A, et al.
Published: (2021) -
Crystallographic analyses of isoquinoline complexes reveal a new mode of metallo-β-lactamase inhibition
by: Li, G, et al.
Published: (2017)